OpenAI CEO Invests in Retro Biosciences to Add 10 Years to Human Lifespan

Have you heard about Retro Biosciences, the startup that aims to add 10 years to the average human lifespan? In mid-2022, the company secured $180 million in funding for their audacious mission, but the identity of the investors remained a mystery until now. In this video, we reveal the man behind the investment - Sam Altman, the CEO of OpenAI. Find out how Altman is pouring millions into Retro Biosciences and another ambitious goal - limitless energy - and what it means for the future.

#humanlongevity #startups #investment #technology #futuretech

"Investor Pours $180 Million into Startup Pursuing Human Longevity"
"Sam Altman Funds Audacious Mission to Extend Human Lifespan"
"Startup Secures $180 Million to Stall Aging: Who's Behind the Investment?"
"OpenAI CEO Invests in Retro Biosciences to Add 10 Years to Human Lifespan"
"Sam Altman: The Tech Investor Funding Limitless Energy and Extended Life Span"
"Investor Pours Millions Into Startup to Help You Live Longer - How It Works!"
"This Investor is Putting All His Money Into Extending Human Life!"
"Revolutionary Startup Secures $180 Million to Fight Aging - Who's Behind It?"
"The Secret Investor Behind a Mission to Add 10 Years to the Human Lifespan!"
"Could This Startup Change the Course of Human Life? Meet the Man Who's Making It Happen!"